InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the full record of transactions filed by Fralick Celeste Rachelle, 董事. Director active across 1 company, notably Aspira Women's Health Inc.. Aggregated, 10 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €3k. Activity tracked since 31 March 2022. The latest transaction was disclosed on 31 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Fralick Celeste Rachelle is Administrateur at Aspira Women's Health Inc. (XNAS). She has 10 filings in total, and in the sampled recent filings between 2022-04-04 and 2025-04-01, buys amount to EUR 2713 and sells to EUR 0; the most frequent transaction nature is Attribution.